You are here: Industry Insights > Roche

News List

MHRA approves Venclyxto for newly diagnosed AML pharmatimes
June 16, 2021
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved AbbVie and Roche’s Venclyxto for the treatment of newly diagnosed acute myeloid leukaemia (AML).
NICE draft guidance does not recommend Evrysdi for SMA pharmatimes
June 04, 2021
The UK National Institute for Health and Care Excellence (NICE) has announced that it does not recommend Roche’s Evrysdi for the treatment of spinal muscular atrophy (SMA) in draft guidance.
Roche Canada Announces Collaboration to Improve Access to Personalized Healthcare with Real World Evidence americanpharmaceuticalreview
June 02, 2021
Hoffmann-La Roche Limited (Roche Canada) announces a joint initiative with BC Cancer and the Canadian Personalized Healthcare Innovation Network (CPHIN) to co-create a real-world evidence (RWE) framework in British Columbia known as the ...
Omar Sherief Mohammad appointed Head India, Middle East & Africa – Roche Diabetes Care expresspharma
June 02, 2021
As head of IMEA, Mohammad will steer the countries under his charge to amplify a patient-centric approach and collaborate with various stakeholders to address the burden of diabetes in the region.
TransThera announces collaboration with Roche to evaluate TT-00420 as part of a novel combination to treat GI cancers in China prnasia
May 27, 2021
TransThera Biosciences Co. Ltd. announced that it has entered into a collaboration agreement with Roche to explore the combination of TT-00420 and atezolizumab for the treatment of patients in China with gastrointestinal ("GI") tract cancers.
Roche UK launches renewable energy initiative with E.ON pharmatimes
May 27, 2021
Roche UK has launched a new renewable energy initiative with E.ON – the energy supplier – to enable the Swiss pharma company’s supply chain partners to purchase 100% renewable energy.
European Commission approves Venclyxto-based combinations for adults with newly diagnosed acute myeloid leukaemia worldpharmanews
May 26, 2021
Roche announced that the European Commission has approved Venclyxto® (venetoclax) in combination with hypomethylating agents, azacitidine and decitabine, for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (AML) who are ...
Cipla to market Roche’s antibody cocktail pan-India, first batch currently available expresspharma
May 25, 2021
Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are at high risk of severe COVID-19.
Roche gives Tocilizumab worth over Rs 40 crores to MoHFW expresspharma
May 14, 2021
The supplies reached India on May 11, 2021, and will be handed over to the MohFW in the next few days.
Novartis signs initial agreement to reserve capacity and implement the technology transfer for the production of the active pharmaceutical ingredient for Roche's Actemra/RoActemra® worldpharmanews
May 08, 2021
Novartis has signed an initial agreement with Roche to reserve capacity and implement the technology transfer for the production of the active pharmaceutical ingredient (API) for Roche's Actemra/RoActemra® (tocilizumab), a treatment for rheumatoid ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page